Ignite Creation Date:
2024-05-06 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 2:17 PM
Study NCT ID:
NCT05111444
Status:
UNKNOWN
Last Update Posted:
2021-11-08
First Post:
2021-10-27
Brief Title:
Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive HER2 Advanced Gastric or Gastroesophageal Junction GEJ Adenocarcinoma
Sponsor:
Organization:
Fudan University